DB18209ExperimentalProtein Based Therapies
NX-210c: Overview.
- Also known as
- Glycine, L-tryptophyl-L-serylglycyl-L-tryptophyl-L-seryl-L-seryl-L-cysteinyl-L-seryl-L-arginyl-L-seryl-L-cysteinyl- · H-L-tryphophanyl-L-seryl-glycyl-L-tryptophanyl-L-seryl-L-seryl-L-cysteinyl-L-seryl-L-arginyl-L-seryl-L-cysteinyl-glycyl-OH (disulfide bond) · SCO-Spondin Derived Peptide NX210
- Code names
- NX210
Resolves to
Compound
Which companies are running trials of NX-210c, in which indications and phases, and which of those programs are still active?
Create a free account or log in to explore the full data card.
Create Account